Health Technology/clinical-trials

Novel Peer Recovery Coach Trial Targets Racial Disparities in Opioid Treatment Access — AI-Enhanced Platform Tested in NYC

247 Health News Editorial

·

12 June 2026

·

4 min read

·clinical-trials

New NYC trial tests AI-enhanced peer recovery coach training to address racial disparities in opioid treatment access among Black and Latinx communities. The innovative platform combines cultural humility training with mobile health technology to improve buprenorphine uptake and social service utilisation.

Originally reported by ClinicalTrials.gov

References

  1. 1.Bassuk, E. L., Hanson, J., Greene, R. N., Richard, M., & Laudet, A. (2016). Peer-delivered recovery support services for addictions in the United States: A systematic review. Journal of Substance Abuse Treatment, 63, 1-9. https://doi.org/10.1016/j.jsat.2016.01.003
  2. 2.Eddie, D., Hoffman, L., Vilsaint, C., Abry, A., Bergman, B., Hoeppner, B., Weinstein, C., & Kelly, J. F. (2019). Lived experience in new models of care for substance use disorder: A systematic review of peer recovery support services and recovery coaching. Frontiers in Psychology, 10, 1052. https://doi.org/10.3389/fpsyg.2019.01052
  3. 3.Friends Research Institute. (2024). Addressing Racial Disparities in Opioid Overdose Deaths Using an Open Source Peer Recovery Coach Training and Multimodal Mobile Health Platform. ClinicalTrials.gov. NCT06573476. https://clinicaltrials.gov/study/NCT06573476
  4. 4.Hansen, H., Siegel, C., Wanderling, J., & DiRocco, D. (2016). Buprenorphine and methadone treatment for opioid dependence by income, ethnicity and race of neighborhoods in New York City. Drug and Alcohol Dependence, 159, 152-160. https://doi.org/10.1016/j.drugalcdep.2015.12.028
  5. 5.Lagisetty, P. A., Ross, R., Bohnert, A., Clay, M., & Maust, D. T. (2019). Buprenorphine treatment divide by race/ethnicity and payment. JAMA Psychiatry, 76(9), 979-981. https://doi.org/10.1001/jamapsychiatry.2019.0876
Share:XLinkedIn
2

247 Health News Editorial

247 Health News is a medical intelligence platform delivering evidence-based research appraisals, clinical trial monitoring, and health technology news for healthcare professionals.

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service